By Alexander Vassallo, Manager of Business Development West Coast (US), Entrepreneurial Education Lead, LSN
Life Science Nation (LSN) attended The MedTech Conference at the Boston Convention & Exhibition Center this week alongside some of the industry’s most innovative technology assets and professional development services. Located at Booth #910 and led by Dennis Ford, Founder and CEO of LSN, this was an exciting opportunity to connect with global players in the medtech industry and begin to build lasting relationships for years to come.
Featuring an array of well-delivered pitches by fundraising executives and interesting panels covering important industry topics, The MedTech Conference powered by AdvaMed provided ample opportunity for networking and establishing the dialogue with key players in the global device sector. Representatives from over 30 countries attended the conference and it was an excellent opportunity for LSN to connect with international groups looking to propagate the growth of their regions’ medical device sectors.
A highlight was connecting with MTPConnect, an Australian-based biotechnology and medical device growth center, which served to further LSN’s relationship with the Australian life sciences community – a relationship that was cemented earlier this year with the engagement of twelve medtech startups from Brisbane Economic Development Agency (BEDA) in LSN’s education curriculum and RESI JPM San Francisco, January 10-12, 2023.
As we approach 2023, maintaining established industry relationships and building new ones through leading partnering events like The MedTech Conference and RESI are essential to continue the growth propagation of the life sciences sector. The opportunity at the Boston Convention & Exhibition Center this week was certainly a rewarding one for all involved. To learn more about RESI and take advantage of exclusive bundles, visit our website and we hope to see you virtually at Digital RESI, November 15-16 and via our hybrid format at RESI JPM San Francisco, January 10-12!
Next Phase Newsletter 
Leave a Reply